HCV Treatment
Boceprevir (Victrelis) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Monday, 16 May 2011 17:02
- Written by Liz Highleyman
Longer Interferon Treatment Raises Hepatitis C Cure Rate
- Details
- Category: HCV Treatment
- Published on Tuesday, 10 May 2011 15:06
- Written by Liz Highleyman
Meta-analysis finds that extending pegylated interferon plus ribavirin to 72 weeks may improve sustained response rates for late-responder genotype 1 hepatitis C patients. 
FDA Committee Unanimously Recommends Telaprevir (Incivek)
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 03 May 2011 16:14
- Written by Liz Highleyman
The FDA Antiviral Drugs Advisory Committee last week voted 18-0 to recommend approval of the HCV protease inhibitor telaprevir (Incivek) for people with genotype 1 chronic hepatitis C.
EASL Releases New Hepatitis C Clinical Practice Guidelines
- Details
- Category: HCV Treatment Guidelines
- Published on Friday, 06 May 2011 14:45
- Written by EASL
EASL updates European guidelines for management of patients with acute and chronic hepatitis C virus (HCV) infection. 
Boceprevir for HCV Wins Unanimous FDA Committee Recommendation
- Details
- Category: Approved HCV Drugs
- Published on Friday, 29 April 2011 14:41
- Written by Liz Highleyman
FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval of protease inhibitor boceprevir (Victrelis) for people with hard-to-treat HCV genotype 1.
Web Design and Development by